We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 10.71%
3 Consumer Discretionary 10.62%
4 Healthcare 9.54%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONO icon
901
Sonos
SONO
$1.86B
$332K 0.01%
9,429
-356
-4% -$13.3K
BCPC
902
Balchem Corp
BCPC
$5.73B
$332K 0.01%
2,529
-88
-3% -$11.3K
FUBO icon
903
FuboTV Inc
FUBO
$293M
$331K 0.01%
+859
New +$245K
HES
904
DELISTED
Hess
HES
$330K 0.01%
3,781
JUST icon
905
Goldman Sachs JUST US Large Cap Equity ETF
JUST
$579M
$330K 0.01%
5,294
+18
+0.3% +$1.09K
SIG icon
906
Signet Jewelers
SIG
$3.59B
$330K 0.01%
4,089
-154
-4% -$9.96K
AIMC
907
DELISTED
Altra Industrial Motion Corp
AIMC
$330K 0.01%
5,081
-166
-3% -$10.6K
AXNX
908
DELISTED
Axonics, Inc. Common Stock
AXNX
$329K 0.01%
5,190
+803
+18% +$47.4K
IP icon
909
International Paper
IP
$21.8B
$328K 0.01%
5,651
-328
-5% -$18.7K
GRMN
910
Garmin
GRMN
$59.8B
$327K 0.01%
2,268
POR icon
911
Portland General Electric
POR
$5.74B
$325K 0.01%
7,059
-262
-4% -$12.9K
SUM
912
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$325K 0.01%
9,484
RSG icon
913
Republic Services
RSG
$65.6B
$324K 0.01%
2,954
-149
-5% -$16K
ARNA
914
DELISTED
Arena Pharmaceuticals Inc
ARNA
$323K 0.01%
4,729
FTV icon
915
Fortive
FTV
$18.6B
$322K 0.01%
6,136
-374
-6% -$20.2K
LPSN icon
916
LivePerson
LPSN
$34.1M
$321K 0.01%
338
BKU icon
917
Bankunited
BKU
$3.38B
$319K 0.01%
7,467
APLS
918
DELISTED
Apellis Pharmaceuticals
APLS
$318K 0.01%
5,030
CDLX icon
919
Cardlytics
CDLX
$24.7M
$318K 0.01%
251
+8
+3% +$9.03K
EIX icon
920
Edison International
EIX
$26.7B
$318K 0.01%
5,506
-443
-7% -$25.8K
CRNC icon
921
Cerence
CRNC
$391M
$317K 0.01%
2,967
-112
-4% -$11K
SHAK icon
922
Shake Shack
SHAK
$2.94B
$317K 0.01%
2,959
+105
+4% +$10.6K
VIAV icon
923
Viavi Solutions
VIAV
$10.6B
$317K 0.01%
17,927
-662
-4% -$11.2K
EXPE icon
924
Expedia Group
EXPE
$39.1B
$316K 0.01%
1,930
VMC icon
925
Vulcan Materials
VMC
$36.3B
$315K 0.01%
1,812
-116
-6% -$20.7K

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.